Alston & Bird, with a team led by Health Care partners Tim Trysla and Brian Lee, represented the Diabetes Technology Access Coalition (DTAC) in advocating for adjustments by the Centers for Medicare & Medicaid Services (CMS) to the billing cycle of continuous glucose monitors (CGM) that will alleviate confusion, frustration, and delays for people with diabetes in need of care.
Currently, the 30-day Medicare billing cycle of CGM supplies is out of sync with the 90-day supply quantity that beneficiaries receive. This fix, which will go into effect on January 1, 2024, will align the billing cycle with the 90-day supply, providing peace of mind to patients and helping to normalize their routines and schedules.
DTAC is a cross-industry group of diabetes stakeholders, including: Advanced Diabetes Supply, Association of Diabetes Care & Education Specialists, Beyond Type 1, Dexcom, Diabetes Leadership Council, JDRF, the Helmsley Charitable Trust, Lifescan, Insulet, Tandem Diabetes Care, and Tidepool.